Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Hypertriglyceridemia, an important and independent risk factor for acute pancreatitis in patients with type 2 diabetes mellitus

Authors Albai O, Roman D, Frandes M

Received 13 February 2017

Accepted for publication 18 March 2017

Published 13 April 2017 Volume 2017:13 Pages 515—522

DOI https://doi.org/10.2147/TCRM.S134560

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Hoa Le

Peer reviewer comments 2

Editor who approved publication: Professor Garry Walsh

Oana Albai,1 Deiana Roman,2 Mirela Frandes2

1Second Department of Internal Medicine, 2Department of Functional Sciences, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania

Purpose: Acute pancreatitis (AP) is a frequent inflammatory disease of the pancreas with multiple causes, among which high triglyceride (TG) level is the most common. The main purpose of this study has been to research the prevalence of AP in patients with diabetes mellitus (DM) and to underline the importance of hypertriglyceridemia (HTG) as a risk factor in triggering AP. The possible link between AP and glycemic control has been studied also, alongside some cardiovascular risk factors and long-term diabetes complications.
Patients and methods: The patient cohort comprised 1,586 patients with DM, admitted to the Internal Medicine Clinic of Diabetes, Nutrition and Metabolic Disease within the Emergency Hospital in Timisoara between January and August 2016. Following a series of clinical and biological investigations, these patients were diagnosed with AP. The patients’ antidiabetic treatment and chronic diabetes-related complications have also been recorded.
Results: The prevalence of pancreatitis in this group of patients was 3.7%. The presence of pancreatitis was associated with a higher HbA1c (8.5% vs 7.7%; P<0.001), fasting glycemia (167.5 vs 95 mg/dL; P<0.001), postprandial glycemia (244.5 vs 118 mg/dL; P<0.001), total cholesterol (256.5 vs 189.5 mg/dL; P<0.001), low-density lipoprotein cholesterol (LDLc) (208.7 vs 112.8 mg/dL; P<0.001), and TGs (495 vs 161 mg/dL; P<0.001). HDL cholesterol (HDLc) was found to be a significant protective factor against the risk of pancreatitis. On the contrary, high LDLc values were a significant risk factor for pancreatitis along with high non-HDLc and high TG values, respectively.
Conclusion: The development of AP events in patients with DM is associated with unsatisfactory glycemic control, HTG, hypertension, and the presence and severity of DM chronic complications. In this study, the prevalence of AP events in patients with DM was 3.7%.

Keywords:
diabetes mellitus, hypertriglyceridemia, acute pancreatitis, insulin resistance

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Association between coping mechanisms and adherence to diabetes-related self-care activities: a cross-sectional study

Albai A, Sima A, Papava I, Roman D, Andor B, Gafencu M

Patient Preference and Adherence 2017, 11:1235-1241

Published Date: 17 July 2017

Instrument for assessing mobile technology acceptability in diabetes self-management: a validation and reliability study

Frandes M, Deiac AV, Timar B, Lungeanu D

Patient Preference and Adherence 2017, 11:259-269

Published Date: 14 February 2017

Urinary tract infections in Romanian patients with diabetes: prevalence, etiology, and risk factors

Chiţă T, Timar B, Muntean D, Bădițoiu L, Horhat F, Hogea E, Moldovan R, Timar R, Licker M

Therapeutics and Clinical Risk Management 2017, 13:1-7

Published Date: 16 December 2016

Factors influencing the quality of life perception in patients with type 2 diabetes mellitus

Timar R, Velea I, Timar B, Lungeanu D, Oancea C, Roman D, Mazilu O

Patient Preference and Adherence 2016, 10:2471-2477

Published Date: 8 December 2016

Impact of neuropathy on the adherence to diabetes-related self-care activities: a cross-sectional study

Timar B, Timar R, Schiller A, Oancea C, Roman D, Vlad M, Balinisteanu B, Mazilu O

Patient Preference and Adherence 2016, 10:1169-1175

Published Date: 1 July 2016